The magnitude of the 2022 multi-country monkeypox virus (MPXV) outbreak has surpassed
any preceding outbreak. It is unclear whether asymptomatic or otherwise undiagnosed …

Background Mpox (formerly monkeypox) is a viral disease caused by the mpox virus (MPXV),
endemic in Central and West Africa and currently causing a global outbreak of …

The risk of infection after exposure to clade IIb mpox virus (MPXV) is unknown, and potential
presymptomatic shedding of MPXV remains to be demonstrated. High‐risk contacts of mpox …

COVID-19 Antibody Detecting Rapid Diagnostic Tests (COVID-19 Ab RDTs) are the
preferred tool for SARS-CoV-2 seroprevalence studies, particularly in low- and middle-income …

Background Hepatitis C virus (HCV) screening is critical to HCV elimination efforts. Simplified
diagnostics are required for low-resource settings and difficult-to-reach populations. This …

Epidemiological data suggest that clade IIb monkeypox virus (MPXV) is readily transmitted
during sexual contact, even before symptom onset. However, presymptomatic shedding of …

Vaccine-induced seroreactivity/positivity (VISR/P) poses a significant and common challenge
to HIV vaccine implementation, as up to 95% of vaccine recipients may be misclassified as …

Background The presentation of mpox clade IIb during the 2022 outbreak overlaps with a
range of other diseases. Understanding the factors associated with mpox is important for …

HIV-1 pol sequences obtained through baseline drug resistance testing of patients newly
diagnosed between 2013 and 2017 were analyzed for genetic similarity. For 927 patients the …

Background To assess the prevalence and evolution of transmitted drug resistance (TDR) in
Belgium, a total of 3708 baseline human immunodeficiency virus (HIV)-1 polymerase …